ABOUT EVALION
We're building the operating system that lets the people running clinical trials see everything, and act only on what matters.
AI is accelerating drug discovery. The trials that turn discoveries into therapies still run on manual data checking, systems that each check only their own records, and problems found months late. Evalion changes that: every record checked against every requirement as it lands, every issue that matters acted on, every decision recorded. For the sponsors, CROs and study teams doing the work.
Built by Builders
Our team
Behind Evalion are three co-founders who bring entrepreneurial scale, technical depth, clinical domain expertise, and deep healthcare investing experience.
Marcelo Camberos
CEO & Co-Founder
Marcelo is a seasoned entrepreneur who scaled IPSY from idea to over $1B in revenue, where he now serves as Chairman after a decade as CEO. He previously founded or was part of the founding team of Real Influence, Funny or Die, and WOBI, and has been recognized as one of Fast Company’s Most Creative People in Business. A Henry Crown Fellow at the Aspen Institute and Stanford MBA, Marcelo brings a track record of building category-defining companies at global scale.
Miguel Andrés
CPTO & Co-Founder
Miguel has over 25 years leading product and engineering teams across the US and Europe. An award-winning former Google leader (top 3% of tech leads/managers worldwide), he has built and scaled technology teams from pre-seed startups through Series B. He previously created one of the first healthcare conversational AI companions, and now leads Evalion's product and engineering organization.
Dr. Mohit (Mo) Kaushal
Co-Founder
Mo is a physician, healthcare entrepreneur, and investor. As an investor and Senior Advisor at General Atlantic, he led and sat on the boards of multiple transformational exits of complex regulatory focused healthcare companies — Oak Street Health (CVS), goBalto (Oracle), and George Clinical (Hillhouse). He served on the Obama White House Health IT task force, built the FCC's first healthcare team, is an adjunct on faculty at Stanford University, and holds an MD from Imperial College London and an MBA from Stanford.
Start with one study.
Tell us about your next study. We price it, show the value on its numbers, and have you live in weeks.